These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34353323)

  • 41. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs.
    Ondocsin J; Ciccarone D; Moran L; Outram S; Werb D; Thomas L; Arnold EA
    Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Everywhere and for everyone: proportionate universalism as a framework for equitable access to community drug checking.
    Wallace B; van Roode T; Burek P; Hore D; Pauly B
    Harm Reduct J; 2022 Dec; 19(1):143. PubMed ID: 36539747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff.
    Aronson ID; Bennett AS; Freeman R
    Harm Reduct J; 2020 Oct; 17(1):77. PubMed ID: 33076911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A scoping review of qualitative research on barriers and facilitators to the use of supervised consumption services.
    Ivsins A; Warnock A; Small W; Strike C; Kerr T; Bardwell G
    Int J Drug Policy; 2023 Jan; 111():103910. PubMed ID: 36436364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Public support for harm reduction: A population survey of Canadian adults.
    Wild TC; Koziel J; Anderson-Baron J; Asbridge M; Belle-Isle L; Dell C; Elliott R; Hathaway A; MacPherson D; McBride K; Pauly B; Strike C; Galovan A; Hyshka E
    PLoS One; 2021; 16(5):e0251860. PubMed ID: 34010338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. "It's an emotional roller coaster… But sometimes it's fucking awesome": Meaning and motivation of work for peers in overdose response environments in British Columbia.
    Pauly BB; Mamdani Z; Mesley L; McKenzie S; Cameron F; Edwards D; Howell A; Knott M; Scott T; Seguin R; Greer AM; Buxton JA
    Int J Drug Policy; 2021 Feb; 88():103015. PubMed ID: 33176249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Using alone at home: What's missing in housing-based responses to the overdose crisis?
    Fleming T; Boyd J; Chayama KL; Knight KR; McNeil R
    Harm Reduct J; 2024 Jan; 21(1):24. PubMed ID: 38281992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Supervised Inhalation Sites: Preventing Overdose and Reducing Health Inequities among People Who Use Drugs.
    Lu A; Kim C; Rosen JG; Thompson E; Tardif J; Welwean R; Park JN
    Subst Use Misuse; 2024; 59(4):520-526. PubMed ID: 38044494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings.
    MacKinnon L; Socías ME; Bardwell G
    J Subst Abuse Treat; 2020 Dec; 119():108153. PubMed ID: 33032862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs.
    Kesten JM; Holland A; Linton MJ; Family H; Scott J; Horwood J; Hickman M; Telfer M; Ayres R; Hussey D; Wilkinson J; Hines LA
    Int J Drug Policy; 2021 Dec; 98():103391. PubMed ID: 34343945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis.
    Mitra S; Bouck Z; Larney S; Zolopa C; Høj S; Minoyan N; Upham K; Rammohan I; Mok WY; Hayashi K; Milloy MJ; DeBeck K; Scheim A; Werb D
    Harm Reduct J; 2024 May; 21(1):94. PubMed ID: 38750575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "It's just not the same": Exploring PWUD' perceptions of and experiences with drug policy and SCS services change in a Canadian City.
    Greene C; Maier K; Urbanik MM
    Int J Drug Policy; 2023 Jan; 111():103934. PubMed ID: 36549200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island.
    Collins AB; Edwards S; McNeil R; Goldman J; Hallowell BD; Scagos RP; Marshall BDL
    Int J Drug Policy; 2022 May; 103():103626. PubMed ID: 35228056
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
    Frost MC; Sweek EW; Austin EJ; Corcorran MA; Juarez AM; Frank ND; Prohaska SM; LaKosky PA; Asher AK; Broz D; Jarlais DCD; Williams EC; Glick SN
    AIDS Behav; 2022 Jan; 26(1):57-68. PubMed ID: 34110506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service.
    Torres-Leguizamon M; Reynaud EG; Néfau T; Duplessy C
    Harm Reduct J; 2020 Aug; 17(1):59. PubMed ID: 32831094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study.
    Ali F; Kaura A; Russell C; Bonn M; Bruneau J; Dasgupta N; Imtiaz S; Martel-Laferrière V; Rehm J; Shahin R; Elton-Marshall T
    Harm Reduct J; 2023 Jul; 20(1):99. PubMed ID: 37516836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
    Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
    Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19.
    Olding M; Barker A; McNeil R; Boyd J
    Int J Drug Policy; 2021 Apr; 90():103076. PubMed ID: 33321286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.